The Oncogenic BRAF Kinase Inhibitor PLX4032/RG7204 Does Not Affect the Viability or Function of Human Lymphocytes Across a Wide Range of Concentrations

PURPOSE: PLX4032 (RG7204), an oncogenic BRAF kinase inhibitor undergoing clinical evaluation, has high response rates in early clinical trials in patients with advanced BRAF(V600E) mutant melanoma. Combining PLX4032 with immunotherapy may allow expanding the durability of responses. The effects of P...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Comin-Anduix, Begoña, Chodon, Thinle, Sazegar, Hooman, Matsunaga, Douglas, Mock, Stephen, Jalil, Jason, Escuin-Ordinas, Helena, Chmielowski, Bartosz, Koya, Richard C., Ribas, Antoni
格式: Artigo
語言:Inglês
出版: 2010
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3057460/
https://ncbi.nlm.nih.gov/pubmed/21169256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-1911
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍